CDA and acute myeloid leukemia: However, by analyzing the mRNA expression profile of the Cancer Genome Atlas (TCGA) dataset, we observed that the expression of UGT1A1 in blast cells from AML patients was nearly negligible in contrast to the main Ara-C inactivating enzyme CDA (Additional file 5: Fig. S3) [39].